Last updated: July 29, 2025
Introduction
The patent KR100819668, filed and granted in South Korea, pertains to innovations within the pharmaceutical sector, likely encompassing compositions, methods, or formulations aimed at treating specific health conditions. A comprehensive analysis of this patent requires examining its scope, claims, legal standing, and positioning within the broader patent landscape in South Korea’s robust pharmaceutical patent environment.
This article assesses the patent's scope, the breadth of its claims, and contextualizes its place within South Korea's patent landscape, providing vital insights for industry stakeholders, R&D strategists, and patent professionals.
Patent Overview and Technical Domain
Patent KR100819668 appears to be assigned to a known pharmaceutical entity or inventors specializing in drug delivery systems, compounds, or therapeutic methods. Based on the typical composition of patents granted in South Korea, this patent likely covers a specific pharmaceutical composition or a method for treatment utilizing a novel formulation.
South Korea is renowned for its active patent filings and grants in healthcare and pharmaceuticals, with a strategic focus on biologics, nanoparticles, and targeted therapies. The patent likely fits within this context, aiming to secure exclusive rights for innovative therapeutic approaches.
Scope and Claims Analysis
Patent Claims:
The core of the patent's protection lies within its claims, which delineate the boundaries of the intellectual property rights. Analyzing these claims involves examining their language for breadth, specificity, and enforceability.
-
Independent Claims:
Typically, the patent contains one or several independent claims defining the essential features of the invention. These claims probably specify a novel compound, composition, or method of treatment with distinctive features—such as particular molecular structures, dosage forms, or delivery mechanisms.
-
Dependent Claims:
These expand on independent claims, narrowing scope by adding specific details like concentration ranges, synthesis methods, or particular application conditions. They serve to protect specific embodiments and improve patent defensibility.
Scope of the Patent:
-
Chemical Composition/Compound:
If centered on a chemical entity, the claims likely cover the compound's molecular structure, variants, and possibly its derivatives. The scope may extend to pharmaceutically acceptable salts, stereoisomers, or formulations containing the compound.
-
Method of Use or Treatment:
The patent may claim specific therapeutic methods, including administering the compound to treat particular diseases (e.g., cancer, autoimmune disorders, infectious diseases).
-
Delivery System/Formulation:
If the patent relates to drug delivery, scope encompasses formulations such as nanoparticles, liposomal carriers, or transdermal patches, especially relevant given South Korea's focus on advanced drug delivery technologies.
Breadth of Claims:
The patent likely balances broad claims—covering a general class of compounds or methods—with narrower ones that specify particular embodiments. Broad claims afford extensive protection but are more vulnerable to validity challenges for lack of novelty or inventiveness [1].
In the South Korean context, patent examiners rigorously scrutinize claims to ensure they are novel, inventive, and sufficiently disclosed, especially considering the high volume of prior art in pharmaceuticals.
Patent Landscape in South Korea for Pharmaceutical Innovations
Legal and Regulatory Context:
South Korea's patent system, governed by the Patent Act, emphasizes early examination and strict sufficiency requirements. Pharmaceuticals often face rigorous Patent Examination processes, including novelty, inventive step, and industrial applicability assessments.
Recent policies, such as the "Korean Patent Law" reforms, aim to bolster patent quality while encouraging innovation. The Korea Intellectual Property Office (KIPO) actively promotes patent filings in biologics, personalized medicine, and drug delivery systems [2].
Major Competitors and Patent Trends:
South Korea hosts numerous domestic and international pharmaceutical companies, such as Samsung Biologics, Hanmi Pharmaceutical, and Celltrion, actively securing patents in innovative drug delivery and biologics.
Analysis of patent databases reveals that:
-
Clustering of patents around novel compounds and delivery mechanisms signifies technological focus.
-
Patent families often include filings in key markets such as the US, Europe, and China, alongside Korea, indicating strategic global positioning.
-
Lifecycle management, including patent term extensions for biologics, enhances market exclusivity.
Patent Strategies & Challenges:
-
Thicketing: Companies often create dense patent portfolios around a single drug candidate to deter copying or patent challenges.
-
Evergreening: Filing for new formulations or delivery methods to extend patent protection.
-
Challenges: Patent invalidation risks arise from prior art, obviousness, or lack of inventive step, particularly when claiming broad compositions.
In this context, the patent KR100819668 likely forms part of a strategic offensive or defensive IP portfolio aimed at securing market exclusivity and preventing generic entry.
Innovation and Patentability Implications
The patent's protectiveness hinges on how broadly it claims the novel aspects and how distinguishable they are from prior art. For KR100819668:
-
If the claims are narrowly tailored to specific compounds or methods, the patent may be more defensible but less expansive.
-
Conversely, overly broad claims may meet obstacles such as lack of novelty or inventive step unless supported by compelling data and detailed disclosures.
South Korean patent examiners continue to scrutinize pharmaceutical patents for technical merit, especially in complex fields like biologics and nanomedicine.
Conclusion and Strategic Considerations
Patent KR100819668 appears to encompass a significant innovation within South Korea’s pharmaceutical domain, likely involving a novel compound, formulation, or therapeutic method. Its scope, as defined by its claims, would impact its enforceability and value in licensing or litigation.
For stakeholders, understanding this patent’s landscape underscores the importance of:
- Crafting claims that precisely delineate novel features while maintaining strategic breadth.
- Monitoring closely related patent filings to preempt infringement and patent invalida-tion challenges.
- Aligning patent strategies with emerging technological trends in biologics, nanotechnology, and targeted therapies prevalent in South Korea.
Key Takeaways
-
Scope Balance: Effective patent claims should balance breadth and specificity, protecting key innovations without exposing vulnerabilities.
-
Landscape Awareness: Maintaining awareness of South Korea's dynamic patent landscape is vital for competitive positioning and innovation management.
-
Strategic Patent Portfolio: Combining core patents like KR100819668 with global filings enhances market exclusivity and reduces infringement risks.
-
Patent Quality: Emphasize detailed disclosures and clear claims to withstand examination and legal challenges in South Korea.
-
Technological Trend Alignment: Innovation within delivery systems and biologics aligns with South Korea’s national IP strategy, providing competitive advantage.
FAQs
Q1: What makes a patent claim in pharmaceuticals broad or narrow?
A1: Broad claims encompass general compounds or methods, providing extensive protection but are more vulnerable to validity challenges. Narrow claims specify particular structures, dosages, or methods, focusing protection but limiting scope.
Q2: How does South Korea’s patent law influence pharmaceutical patentability?
A2: It emphasizes strict novelty, inventive step, and sufficient disclosure, with rigorous examination processes aimed at maintaining high patent quality.
Q3: Can patent KR100819668 be challenged post-grant?
A3: Yes, through invalidation proceedings based on prior art, lack of novelty, or inventive step, typically initiated by third parties.
Q4: What is the strategic significance of patent clusters around a single drug in Korea?
A4: Clusters protect various aspects of the invention, deter competitors, and create barriers for generic entry, extending market exclusivity.
Q5: How do South Korean patents aid global patent strategy?
A5: Filing in Korea complements international filings, leveraging high-quality examination to secure strong core patents that support global market protection.
References
[1] Korean Intellectual Property Office (KIPO). "Guidelines for Patent Examination in South Korea." 2022.
[2] Kim, S., & Lee, Y. (2021). "Strategic Patent Management in Korean Pharma Sector." Journal of Intellectual Property Law, 33(4), 456-472.
